Related Experiment Video
Updated: May 18, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Epileptic spasms: experience with a high-dose oral corticosteroid protocol
Tyson L Ware1, Mark T Mackay, A Simon Harvey
1Department of Neurology, Parkville University of Melbourne, Melbourne, Victoria, Australia.
Insights
High-dose oral prednisolone is effective for infantile epileptic spasms, showing high remission rates in non-tuberous sclerosis complex (TSC) infants. Vigabatrin was less effective in TSC patients, suggesting early steroid therapy consideration.
Area of Science:
- Pediatric Neurology
- Clinical Practice Audit
Background:
- Infantile epileptic spasms (IES) require effective treatment protocols.
- Assessing adherence to and outcomes of a new IES treatment protocol was needed.
Purpose of the Study:
- To audit clinical practice for infantile epileptic spasms.
- To assess early outcomes of infants treated with an agreed initial treatment protocol.
Main Methods:
- Retrospective review of 28 infants diagnosed with epileptic spasms between July 2007 and June 2009.
- Assessed adherence to a protocol using high-dose oral prednisolone (or vigabatrin for tuberous sclerosis complex - TSC) and evaluated remission by day 14, recurrence, and side effects.
Main Results:
- 100% remission by day 14 in cryptogenic IES treated per protocol.
- 64% remission in non-TSC symptomatic IES treated per protocol vs. 20% not per protocol.
- 17% remission in TSC infants treated with vigabatrin per protocol.
Conclusions:
- High-dose oral prednisolone is effective and tolerable for infantile epileptic spasms.
- The protocol supports high-dose oral prednisolone as a treatment of choice for non-TSC symptomatic IES.
- Early consideration of steroid therapy is warranted given poor vigabatrin response in TSC.
Aim:
To audit clinical practice and assess early outcomes for infants with epileptic spasms after an agreed initial treatment protocol was adopted.
Methods:
We reviewed all cases of epileptic spasms diagnosed between July 2007 and June 2009 and assessed adherence to protocol, remission by day 14, spasm recurrence and side effects. The protocol required that infants be treated with high-dose oral prednisolone except those with tuberous sclerosis complex (TSC) who were treated with vigabatrin.
Results:
Twenty-eight infants (age 3-14 months, 17 male) were newly diagnosed. Six (21%) had no cause identified (cryptogenic), six (21%) had TSC and 16 (57%) had other non-TSC symptomatic aetiologies. Twenty-three were treated per protocol and five were not. The proportion with remission by day 14 of treatment was 100% in the cryptogenic group (all treated per protocol), 64% in those with non-TSC symptomatic aetiologies treated per protocol, 20% in those with non-TSC symptomatic aetiologies treated not per protocol and 17% in infants with TSC (all treated per protocol). Of 17 infants who received prednisolone, two were admitted for management of febrile illness.
Conclusion:
Our experience with high-dose oral prednisolone for treatment of epileptic spasms suggests that it is effective and tolerable. The greater proportion of non-TSC symptomatic patients with timely cessation of spasms when treated by this protocol supports the use of high-dose oral prednisolone as the treatment of choice. Given the poor response of children with TSC to treatment with vigabatrin, early use of steroid therapy deserves consideration.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Dosage Regimen: Multiple Oral Dosage
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Dosage Regimen: Individualization
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

